Acrux developed Nitroglycerine 0.4% Ointment which was approved by the FDA in 2024. The product is licensed to TruPharma. It was launched in the United States in December 2024.
Nitroglycerine 0.4% Ointment is indicated for the topical treatment of moderate to severe pain associated with chronic anal fissure. Refer to the Prescribing Information for further information on the product.